<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02817880</url>
  </required_header>
  <id_info>
    <org_study_id>38RC15.158</org_study_id>
    <nct_id>NCT02817880</nct_id>
  </id_info>
  <brief_title>Comparison of the Analgesic Effect Between the Motor Cortex Stimulation and the Trans-spinal Stimulation in the Algoneurodystrophy.</brief_title>
  <acronym>ALGOSTIM</acronym>
  <official_title>Comparison of the Analgesic Effect Between the Motor Cortex Stimulation (tDCS and rTMS) and the Trans-spinal Stimulation (tsDCS ) in the Algoneurodystrophy of Members. A Randomised Clinical Trial. tDCS : Transcranial Direct-current Stimulation rTMS : Repetitive Transcranial Magnetic Stimulation tsDCS : Transcutaneous Spinal Direct Current Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the analgesic effectiveness of two motor cortex
      neurostimulations (tDCS and rTMS) and the trans-spinal neurostimulation (tsDCS ) in the
      algoneurodystrophy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Entry into the study : After informed consent, patients will be randomised into three
           groups : tDCS, rTMS, tsDCS. The physician responsible for conducting neurostimulation
           sessions will make the randomization via an interactive web response system (IWRS).

        -  Baseline : Participants, will record on a book, a daily Visual Numeric Scale(VNS) of
           Pain Intensity for 1 month.

        -  The beginning of the treatment : after the baseline, sessions of neurostimulation will
           begin. Sessions of neurostimulation will have a decreasing rhythm. Five sessions per
           week during the two first weeks, two sessions per week during the third week, one
           session during the fourth week and then two sessions per month for four months.

        -  After the end of neurostimulation sessions, patients will be followed for 1month.

      Throughout their participation in the study, patients will complete their VNS report book
      (1month of baseline before the treatment, 3 months during neurostimulation, 1 month after
      neurostimulation).

      Patients will have 5 evaluation examinations:

        -  The first, one just before the beginning of the neurostimulation,

        -  The second, 1 month after the beginning of neurostimulation

        -  The third, 3 months after the beginning of neurostimulation

        -  And the last one, 1 month after the end of neurostimulation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 25, 2016</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Visual numeric scale of pain between the three groups</measure>
    <time_frame>Baseline to 1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Clinical Global Impression scale (CGI) between the three groups</measure>
    <time_frame>Baseline, 3 months after the beginning of the treatment (day 90), and 1 month after the end of the treatment (Day 180)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The SF12 quality of life questionnaire between the three groups</measure>
    <time_frame>Baseline, 3 months after the beginning of the treatment (day 90), and 1 month after the end of the treatment (Day 180)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Hospital Anxiety and Depression scale (HAD) between the three groups</measure>
    <time_frame>Baseline, 3 months after the beginning of the treatment (day 90), and 1 month after the end of the treatment (Day 180)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Neuropathic Pain Symptom Inventory scale (NPSI) between the three groups</measure>
    <time_frame>Baseline, 3 months after the beginning of the treatment (day 90), and 1 month after the end of the treatment (Day 180)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of the conductance of feet and hands by using Sudoscan</measure>
    <time_frame>Baseline, 3 months after the beginning of the treatment (day 90), and 1 month after the end of the treatment (Day 180)</time_frame>
    <description>The body conductance will be used to assess the evolution of the Impact of the neurostimulation on the sympathetic nervous system and on the small fiber neuropathy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modifications of the sensori-motor cortical cards by using a MRI</measure>
    <time_frame>Baseline, and 1 month after the end of the treatment (Day 180)</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Algoneurodystrophy</condition>
  <arm_group>
    <arm_group_label>rTMS (repetitive transcranial magnetic stimulation)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rTMS (repetitive transcranial magnetic stimulation)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tDCS (transcranial direct-current stimulation)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>tDCS (transcranial direct-current stimulation)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tsDCS (transcutaneous spinal Direct Current Stimulation)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>tsDCS (transcutaneous spinal Direct Current Stimulation)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rTMS</intervention_name>
    <arm_group_label>rTMS (repetitive transcranial magnetic stimulation)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tDCS</intervention_name>
    <arm_group_label>tDCS (transcranial direct-current stimulation)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tsDCS</intervention_name>
    <arm_group_label>tsDCS (transcutaneous spinal Direct Current Stimulation)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient's written consent

          -  Patient suffering from an algoneurodystrophy for more than a year.

          -  Diagnosis of algoneurodystrophy confirmed by an osseous scintigraphy

          -  Stable treatment for at least 1 month

          -  Patient non-responsive to pharmacological treatments

          -  VNS &gt; 3 at the time of screening

        Exclusion Criteria:

          -  Drug addiction

          -  History of epilepsy, head trauma, Psychiatric pathology likely to hamper the progress
             of the study.

          -  Intracranial ferromagnetic material or an implanted stimulator

          -  MRI contraindication

          -  Algoneurodystrophy due to a nervous lesion

          -  Pregnant women, parturient women, breast-feeding mother. Lack of effective
             contraception
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>HASAN HODAJ, MD</last_name>
    <phone>0476765213</phone>
    <phone_ext>+33</phone_ext>
    <email>HHodaj@chu-grenoble.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service de Physiologie - Explorations Fonctionnelles, Hôpital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <state>Ile de France</state>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Pascal LEFAUCHEUR, MD-PHD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre de la douleur, CHU Grenoble Alpes</name>
      <address>
        <city>Grenoble</city>
        <state>Isere</state>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hasan HODAJ, MD</last_name>
      <phone>0476765213</phone>
      <phone_ext>+33</phone_ext>
      <email>HHodaj@chu-grenoble.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.sciencedirect.com/science/article/pii/S1624568714001048</url>
  </link>
  <reference>
    <citation>Lefaucheur JP, Drouot X, Ménard-Lefaucheur I, Keravel Y, Nguyen JP. Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain. Neurology. 2006 Nov 14;67(9):1568-74.</citation>
    <PMID>17101886</PMID>
  </reference>
  <reference>
    <citation>de Andrade DC, Mhalla A, Adam F, Texeira MJ, Bouhassira D. Neuropharmacological basis of rTMS-induced analgesia: the role of endogenous opioids. Pain. 2011 Feb;152(2):320-6. doi: 10.1016/j.pain.2010.10.032. Epub 2010 Dec 10.</citation>
    <PMID>21146300</PMID>
  </reference>
  <reference>
    <citation>Lefaucheur JP, André-Obadia N, Poulet E, Devanne H, Haffen E, Londero A, Cretin B, Leroi AM, Radtchenko A, Saba G, Thai-Van H, Litré CF, Vercueil L, Bouhassira D, Ayache SS, Farhat WH, Zouari HG, Mylius V, Nicolier M, Garcia-Larrea L. [French guidelines on the use of repetitive transcranial magnetic stimulation (rTMS): safety and therapeutic indications]. Neurophysiol Clin. 2011 Dec;41(5-6):221-95. doi: 10.1016/j.neucli.2011.10.062. Epub 2011 Nov 10. French.</citation>
    <PMID>22153574</PMID>
  </reference>
  <reference>
    <citation>Lefaucheur JP, Ménard-Lefaucheur I, Goujon C, Keravel Y, Nguyen JP. Predictive value of rTMS in the identification of responders to epidural motor cortex stimulation therapy for pain. J Pain. 2011 Oct;12(10):1102-11. doi: 10.1016/j.jpain.2011.05.004. Epub 2011 Jul 31.</citation>
    <PMID>21807565</PMID>
  </reference>
  <reference>
    <citation>Lefaucheur, J. P. (2007).</citation>
  </reference>
  <reference>
    <citation>Khedr EM, Kotb H, Kamel NF, Ahmed MA, Sadek R, Rothwell JC. Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry. 2005 Jun;76(6):833-8.</citation>
    <PMID>15897507</PMID>
  </reference>
  <reference>
    <citation>Passard A, Attal N, Benadhira R, Brasseur L, Saba G, Sichere P, Perrot S, Januel D, Bouhassira D. Effects of unilateral repetitive transcranial magnetic stimulation of the motor cortex on chronic widespread pain in fibromyalgia. Brain. 2007 Oct;130(Pt 10):2661-70. Epub 2007 Sep 14.</citation>
    <PMID>17872930</PMID>
  </reference>
  <reference>
    <citation>Lefaucheur JP, André-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, Cantello RM, Cincotta M, de Carvalho M, De Ridder D, Devanne H, Di Lazzaro V, Filipović SR, Hummel FC, Jääskeläinen SK, Kimiskidis VK, Koch G, Langguth B, Nyffeler T, Oliviero A, Padberg F, Poulet E, Rossi S, Rossini PM, Rothwell JC, Schönfeldt-Lecuona C, Siebner HR, Slotema CW, Stagg CJ, Valls-Sole J, Ziemann U, Paulus W, Garcia-Larrea L. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014 Nov;125(11):2150-206. doi: 10.1016/j.clinph.2014.05.021. Epub 2014 Jun 5. Review.</citation>
    <PMID>25034472</PMID>
  </reference>
  <reference>
    <citation>Leung A, Donohue M, Xu R, Lee R, Lefaucheur JP, Khedr EM, Saitoh Y, André-Obadia N, Rollnik J, Wallace M, Chen R. rTMS for suppressing neuropathic pain: a meta-analysis. J Pain. 2009 Dec;10(12):1205-16. doi: 10.1016/j.jpain.2009.03.010. Epub 2009 May 23. Review.</citation>
    <PMID>19464959</PMID>
  </reference>
  <reference>
    <citation>Lefaucheur JP. Use of repetitive transcranial magnetic stimulation in pain relief. Expert Rev Neurother. 2008 May;8(5):799-808. doi: 10.1586/14737175.8.5.799. Review.</citation>
    <PMID>18457536</PMID>
  </reference>
  <reference>
    <citation>Nitsche MA, Liebetanz D, Lang N, Antal A, Tergau F, Paulus W. Safety criteria for transcranial direct current stimulation (tDCS) in humans. Clin Neurophysiol. 2003 Nov;114(11):2220-2; author reply 2222-3.</citation>
    <PMID>14580622</PMID>
  </reference>
  <reference>
    <citation>Nitsche MA, Paulus W. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology. 2001 Nov 27;57(10):1899-901.</citation>
    <PMID>11723286</PMID>
  </reference>
  <reference>
    <citation>Medeiros LF, de Souza IC, Vidor LP, de Souza A, Deitos A, Volz MS, Fregni F, Caumo W, Torres IL. Neurobiological effects of transcranial direct current stimulation: a review. Front Psychiatry. 2012 Dec 28;3:110. doi: 10.3389/fpsyt.2012.00110. eCollection 2012.</citation>
    <PMID>23293607</PMID>
  </reference>
  <reference>
    <citation>Thibaut A, Chatelle C, Gosseries O, Laureys S, Bruno MA. [Transcranial direct current stimulation: a new tool for neurostimulation]. Rev Neurol (Paris). 2013 Feb;169(2):108-20. doi: 10.1016/j.neurol.2012.05.008. Epub 2012 Sep 7. French.</citation>
    <PMID>22959705</PMID>
  </reference>
  <reference>
    <citation>Fregni F, Gimenes R, Valle AC, Ferreira MJ, Rocha RR, Natalle L, Bravo R, Rigonatti SP, Freedman SD, Nitsche MA, Pascual-Leone A, Boggio PS. A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia. Arthritis Rheum. 2006 Dec;54(12):3988-98.</citation>
    <PMID>17133529</PMID>
  </reference>
  <reference>
    <citation>Antal A, Kriener N, Lang N, Boros K, Paulus W. Cathodal transcranial direct current stimulation of the visual cortex in the prophylactic treatment of migraine. Cephalalgia. 2011 May;31(7):820-8. doi: 10.1177/0333102411399349. Epub 2011 Mar 11.</citation>
    <PMID>21398419</PMID>
  </reference>
  <reference>
    <citation>Fregni F, Boggio PS, Lima MC, Ferreira MJ, Wagner T, Rigonatti SP, Castro AW, Souza DR, Riberto M, Freedman SD, Nitsche MA, Pascual-Leone A. A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury. Pain. 2006 May;122(1-2):197-209. Epub 2006 Mar 27.</citation>
    <PMID>16564618</PMID>
  </reference>
  <reference>
    <citation>Mori F, Codecà C, Kusayanagi H, Monteleone F, Buttari F, Fiore S, Bernardi G, Koch G, Centonze D. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. J Pain. 2010 May;11(5):436-42. doi: 10.1016/j.jpain.2009.08.011. Epub 2009 Dec 16.</citation>
    <PMID>20018567</PMID>
  </reference>
  <reference>
    <citation>Antal A, Terney D, Kühnl S, Paulus W. Anodal transcranial direct current stimulation of the motor cortex ameliorates chronic pain and reduces short intracortical inhibition. J Pain Symptom Manage. 2010 May;39(5):890-903. doi: 10.1016/j.jpainsymman.2009.09.023.</citation>
    <PMID>20471549</PMID>
  </reference>
  <reference>
    <citation>O'Connell NE, Wand BM, Marston L, Spencer S, Desouza LH. Non-invasive brain stimulation techniques for chronic pain. A report of a Cochrane systematic review and meta-analysis. Eur J Phys Rehabil Med. 2011 Jun;47(2):309-26. Epub 2011 Apr 14. Review.</citation>
    <PMID>21494222</PMID>
  </reference>
  <reference>
    <citation>Zaghi S, Thiele B, Pimentel D, Pimentel T, Fregni F. Assessment and treatment of pain with non-invasive cortical stimulation. Restor Neurol Neurosci. 2011;29(6):439-51. doi: 10.3233/RNN-2011-0615.</citation>
    <PMID>22124038</PMID>
  </reference>
  <reference>
    <citation>Luedtke K, Rushton A, Wright C, Geiss B, Juergens TP, May A. Transcranial direct current stimulation for the reduction of clinical and experimentally induced pain: a systematic review and meta-analysis. Clin J Pain. 2012 Jun;28(5):452-61. doi: 10.1097/AJP.0b013e31823853e3. Review.</citation>
    <PMID>22569218</PMID>
  </reference>
  <reference>
    <citation>O'Connell NE, Wand BM, Marston L, Spencer S, Desouza LH. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database Syst Rev. 2014 Apr 11;(4):CD008208. doi: 10.1002/14651858.CD008208.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 Mar 16;3:CD008208.</citation>
    <PMID>24729198</PMID>
  </reference>
  <reference>
    <citation>Cogiamanian F, Vergari M, Pulecchi F, Marceglia S, Priori A. Effect of spinal transcutaneous direct current stimulation on somatosensory evoked potentials in humans. Clin Neurophysiol. 2008 Nov;119(11):2636-40. doi: 10.1016/j.clinph.2008.07.249. Epub 2008 Sep 10.</citation>
    <PMID>18786856</PMID>
  </reference>
  <reference>
    <citation>Truini A, Vergari M, Biasiotta A, La Cesa S, Gabriele M, Di Stefano G, Cambieri C, Cruccu G, Inghilleri M, Priori A. Transcutaneous spinal direct current stimulation inhibits nociceptive spinal pathway conduction and increases pain tolerance in humans. Eur J Pain. 2011 Nov;15(10):1023-7. doi: 10.1016/j.ejpain.2011.04.009. Epub 2011 May 14.</citation>
    <PMID>21576030</PMID>
  </reference>
  <reference>
    <citation>Toshev PK, Guleyupoglu B, Bikson M. Informing dose design by modeling transcutaneous spinal direct current stimulation. Clin Neurophysiol. 2014 Nov;125(11):2147-9. doi: 10.1016/j.clinph.2014.03.022. Epub 2014 Apr 4.</citation>
    <PMID>24775922</PMID>
  </reference>
  <reference>
    <citation>Priori A, Ciocca M, Parazzini M, Vergari M, Ferrucci R. Transcranial cerebellar direct current stimulation and transcutaneous spinal cord direct current stimulation as innovative tools for neuroscientists. J Physiol. 2014 Aug 15;592(16):3345-69. doi: 10.1113/jphysiol.2013.270280. Epub 2014 Jun 6. Review.</citation>
    <PMID>24907311</PMID>
  </reference>
  <reference>
    <citation>Cogiamanian F, Ardolino G, Vergari M, Ferrucci R, Ciocca M, Scelzo E, Barbieri S, Priori A. Transcutaneous spinal direct current stimulation. Front Psychiatry. 2012 Jul 4;3:63. doi: 10.3389/fpsyt.2012.00063. eCollection 2012.</citation>
    <PMID>22783208</PMID>
  </reference>
  <reference>
    <citation>Plow EB, Pascual-Leone A, Machado A. Brain stimulation in the treatment of chronic neuropathic and non-cancerous pain. J Pain. 2012 May;13(5):411-24. doi: 10.1016/j.jpain.2012.02.001. Epub 2012 Apr 7. Review.</citation>
    <PMID>22484179</PMID>
  </reference>
  <reference>
    <citation>Lefaucheur JP, Antal A, Ahdab R, Ciampi de Andrade D, Fregni F, Khedr EM, Nitsche M, Paulus W. The use of repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) to relieve pain. Brain Stimul. 2008 Oct;1(4):337-44. doi: 10.1016/j.brs.2008.07.003. Epub 2008 Oct 7. Review.</citation>
    <PMID>20633392</PMID>
  </reference>
  <reference>
    <citation>Fregni F, Freedman S, Pascual-Leone A. Recent advances in the treatment of chronic pain with non-invasive brain stimulation techniques. Lancet Neurol. 2007 Feb;6(2):188-91. Review.</citation>
    <PMID>17239806</PMID>
  </reference>
  <reference>
    <citation>Nizard J, Lefaucheur JP, Helbert M, de Chauvigny E, Nguyen JP. Non-invasive stimulation therapies for the treatment of refractory pain. Discov Med. 2012 Jul;14(74):21-31. Review.</citation>
    <PMID>22846200</PMID>
  </reference>
  <reference>
    <citation>Mhalla A, Baudic S, Ciampi de Andrade D, Gautron M, Perrot S, Teixeira MJ, Attal N, Bouhassira D. Long-term maintenance of the analgesic effects of transcranial magnetic stimulation in fibromyalgia. Pain. 2011 Jul;152(7):1478-85. doi: 10.1016/j.pain.2011.01.034. Epub 2011 Mar 11.</citation>
    <PMID>21397400</PMID>
  </reference>
  <reference>
    <citation>Zaghi S, DaSilva AF, Acar M, Lopes M, Fregni F. One-year rTMS treatment for refractory trigeminal neuralgia. J Pain Symptom Manage. 2009 Oct;38(4):e1-5. doi: 10.1016/j.jpainsymman.2009.04.020. Epub 2009 Aug 26. Erratum in: J Pain Symptom Manage. 2010 Dec;40(6):e9.</citation>
    <PMID>19713068</PMID>
  </reference>
  <reference>
    <citation>Lefaucheur JP, Drouot X, Ménard-Lefaucheur I, Nguyen JP. Neuropathic pain controlled for more than a year by monthly sessions of repetitive transcranial magnetic stimulation of the motor cortex. Neurophysiol Clin. 2004 Apr;34(2):91-5.</citation>
    <PMID>15130555</PMID>
  </reference>
  <reference>
    <citation>Hodaj H, Alibeu JP, Payen JF, Lefaucheur JP. Treatment of Chronic Facial Pain Including Cluster Headache by Repetitive Transcranial Magnetic Stimulation of the Motor Cortex With Maintenance Sessions: A Naturalistic Study. Brain Stimul. 2015 Jul-Aug;8(4):801-7. doi: 10.1016/j.brs.2015.01.416. Epub 2015 Feb 7.</citation>
    <PMID>25979838</PMID>
  </reference>
  <reference>
    <citation>Kim YJ, Ku J, Kim HJ, Im DJ, Lee HS, Han KA, Kang YJ. Randomized, sham controlled trial of transcranial direct current stimulation for painful diabetic polyneuropathy. Ann Rehabil Med. 2013 Dec;37(6):766-76. doi: 10.5535/arm.2013.37.6.766. Epub 2013 Dec 23.</citation>
    <PMID>24466511</PMID>
  </reference>
  <reference>
    <citation>Nitsche MA, Cohen LG, Wassermann EM, Priori A, Lang N, Antal A, Paulus W, Hummel F, Boggio PS, Fregni F, Pascual-Leone A. Transcranial direct current stimulation: State of the art 2008. Brain Stimul. 2008 Jul;1(3):206-23. doi: 10.1016/j.brs.2008.06.004. Epub 2008 Jul 1. Review.</citation>
    <PMID>20633386</PMID>
  </reference>
  <reference>
    <citation>Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009 Dec;120(12):2008-39. doi: 10.1016/j.clinph.2009.08.016. Epub 2009 Oct 14. Review.</citation>
    <PMID>19833552</PMID>
  </reference>
  <reference>
    <citation>Picarelli H, Teixeira MJ, de Andrade DC, Myczkowski ML, Luvisotto TB, Yeng LT, Fonoff ET, Pridmore S, Marcolin MA. Repetitive transcranial magnetic stimulation is efficacious as an add-on to pharmacological therapy in complex regional pain syndrome (CRPS) type I. J Pain. 2010 Nov;11(11):1203-10. doi: 10.1016/j.jpain.2010.02.006. Epub 2010 Apr 28.</citation>
    <PMID>20430702</PMID>
  </reference>
  <reference>
    <citation>M. Sorel, J.-P. Lefaucheur, J.-C. Beatrix, A.M. Domec, M.L. Giboutet, E. Houy, J. Robert, P. Cesaro (2012); Complex regional pain syndrome: interest in coupling the vascular phase of technetium 99 bone scintigraphy with the effectiveness of ketamine. Lett. Méd. Phys. Réadapt., OI 10.1007/s11659-012-0296-1</citation>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2016</study_first_submitted>
  <study_first_submitted_qc>June 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2016</study_first_posted>
  <last_update_submitted>October 25, 2017</last_update_submitted>
  <last_update_submitted_qc>October 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>rTMS, tDCS, tsDCS, pain, algoneurodystrophy , neurostimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
    <mesh_term>Complex Regional Pain Syndromes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

